These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18537663)

  • 1. Cyclooxygenase inhibition in ischemic brain injury.
    Candelario-Jalil E; Fiebich BL
    Curr Pharm Des; 2008; 14(14):1401-18. PubMed ID: 18537663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The highly selective cyclooxygenase-2 inhibitor DFU is neuroprotective when given several hours after transient cerebral ischemia in gerbils.
    Candelario-Jalil E; Alvarez D; Castañeda JM; Al-Dalain SM; Martínez-Sánchez G; Merino N; León OS
    Brain Res; 2002 Feb; 927(2):212-5. PubMed ID: 11821016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research.
    Choi SH; Aid S; Bosetti F
    Trends Pharmacol Sci; 2009 Apr; 30(4):174-81. PubMed ID: 19269697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia.
    Candelario-Jalil E; González-Falcón A; García-Cabrera M; Alvarez D; Al-Dalain S; Martínez G; León OS; Springer JE
    J Neurochem; 2003 Aug; 86(3):545-55. PubMed ID: 12859668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture.
    Hewett SJ; Uliasz TF; Vidwans AS; Hewett JA
    J Pharmacol Exp Ther; 2000 May; 293(2):417-25. PubMed ID: 10773011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-1 and -2 knockout mice demonstrate increased cardiac ischemia/reperfusion injury but are protected by acute preconditioning.
    Camitta MG; Gabel SA; Chulada P; Bradbury JA; Langenbach R; Zeldin DC; Murphy E
    Circulation; 2001 Nov; 104(20):2453-8. PubMed ID: 11705824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inhibition of cyclooxygenase-2 induces dendritic hypertrophy and limited functional improvement following motor cortex stroke.
    Silasi G; Kolb B
    Neuroscience; 2007 Feb; 144(4):1160-8. PubMed ID: 17175107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of hippocampal neuronal damage after transient forebrain ischemia in cyclooxygenase-2-deficient mice.
    Sasaki T; Kitagawa K; Yamagata K; Takemiya T; Tanaka S; Omura-Matsuoka E; Sugiura S; Matsumoto M; Hori M
    J Cereb Blood Flow Metab; 2004 Jan; 24(1):107-13. PubMed ID: 14688622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene.
    Nagayama M; Niwa K; Nagayama T; Ross ME; Iadecola C
    J Cereb Blood Flow Metab; 1999 Nov; 19(11):1213-9. PubMed ID: 10566967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice.
    Reese J; Zhao X; Ma WG; Brown N; Maziasz TJ; Dey SK
    Endocrinology; 2001 Jul; 142(7):3198-206. PubMed ID: 11416042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healing impairment effect of cyclooxygenase inhibitors on dextran sulfate sodium-induced colitis in rats.
    Tsubouchi R; Hayashi S; Aoi Y; Nishio H; Terashima S; Kato S; Takeuchi K
    Digestion; 2006; 74(2):91-100. PubMed ID: 17143008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective efficacy of nimesulide against hippocampal neuronal damage following transient forebrain ischemia.
    Candelario-Jalil E; Alvarez D; González-Falcón A; García-Cabrera M; Martínez-Sánchez G; Merino N; Giuliani A; León OS
    Eur J Pharmacol; 2002 Oct; 453(2-3):189-95. PubMed ID: 12398903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.
    Belton OA; Duffy A; Toomey S; Fitzgerald DJ
    Circulation; 2003 Dec; 108(24):3017-23. PubMed ID: 14638539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors.
    Katori M; Majima M
    Inflamm Res; 2000 Aug; 49(8):367-92. PubMed ID: 11028754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-1-selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus.
    Loftin CD; Trivedi DB; Langenbach R
    J Clin Invest; 2002 Aug; 110(4):549-57. PubMed ID: 12189249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-1 and -2 enzymes differentially regulate the brain upstream NF-kappa B pathway and downstream enzymes involved in prostaglandin biosynthesis.
    Choi SH; Langenbach R; Bosetti F
    J Neurochem; 2006 Aug; 98(3):801-11. PubMed ID: 16787416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased susceptibility to ischemic brain injury in cyclooxygenase-1-deficient mice.
    Iadecola C; Sugimoto K; Niwa K; Kazama K; Ross ME
    J Cereb Blood Flow Metab; 2001 Dec; 21(12):1436-41. PubMed ID: 11740205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2: a therapeutic target.
    Turini ME; DuBois RN
    Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage.
    Tanaka A; Hase S; Miyazawa T; Takeuchi K
    J Pharmacol Exp Ther; 2002 Mar; 300(3):754-61. PubMed ID: 11861778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.